- Home
- FBIOP vs FCNCO Comparison
FBIOP vs FCNCO Comparison
Compare FBIOP & FCNCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- FCNCO
- Stock Information
- Founded
- FBIOP N/A
- FCNCO 1898
- Country
- FBIOP United States
- FCNCO United States
- Employees
- FBIOP 101
- FCNCO N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- FCNCO Major Banks
- Sector
- FBIOP Health Care
- FCNCO Finance
- Exchange
- FBIOP Nasdaq
- FCNCO Nasdaq
- Market Cap
- FBIOP N/A
- FCNCO N/A
- IPO Year
- FBIOP N/A
- FCNCO N/A
- Fundamental
- Price
- FBIOP $9.47
- FCNCO $21.56
- Analyst Decision
- FBIOP
- FCNCO
- Analyst Count
- FBIOP 0
- FCNCO 0
- Target Price
- FBIOP N/A
- FCNCO N/A
- AVG Volume (30 Days)
- FBIOP N/A
- FCNCO 22.4K
- Earning Date
- FBIOP N/A
- FCNCO 07-24-2025
- Dividend Yield
- FBIOP N/A
- FCNCO 6.54%
- EPS Growth
- FBIOP N/A
- FCNCO N/A
- EPS
- FBIOP N/A
- FCNCO 175.01
- Revenue
- FBIOP N/A
- FCNCO $9,091,000,000.00
- Revenue This Year
- FBIOP N/A
- FCNCO N/A
- Revenue Next Year
- FBIOP N/A
- FCNCO $2.54
- P/E Ratio
- FBIOP N/A
- FCNCO $9.93
- Revenue Growth
- FBIOP N/A
- FCNCO N/A
- 52 Week Low
- FBIOP N/A
- FCNCO $20.57
- 52 Week High
- FBIOP N/A
- FCNCO $24.83
- Technical
- Relative Strength Index (RSI)
- FBIOP 85.14
- FCNCO 38.24
- Support Level
- FBIOP $6.43
- FCNCO $21.35
- Resistance Level
- FBIOP $7.00
- FCNCO $21.62
- Average True Range (ATR)
- FBIOP 0.41
- FCNCO 0.27
- MACD
- FBIOP 0.25
- FCNCO -0.14
- Stochastic Oscillator
- FBIOP 99.37
- FCNCO 20.00
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About FCNCO First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.